Search for: "Janssen v. Eli Lilly and Company"
Results 1 - 20
of 30
Sorted by Relevance
|
Sort by Date
21 Feb 2016, 1:44 am
Are the undertakings offered by Janssen sufficient to reduce the commercial uncertainty faced by Eli Lilly to an acceptable level if a stay is granted? [read post]
4 Apr 2017, 2:51 am
Even though IP rights have been mentioned in IIAs as protected investments for decades, Eli Lilly v. [read post]
14 Feb 2010, 4:20 pm
Cir. 2009) Eli Lilly & Co. v. [read post]
9 Nov 2010, 4:30 am
The state's case was based on claims that J&J and Janssen sent 7,604 "Dear Doctor" letters to Louisiana medical providers and made a total of 27,542 sales calls, in which company representatives claimed that Risperdal was safer than competing antipsychotic drugs such as Eli Lilly's Zyprexa and AstraZeneca's Seroquel. [read post]
21 Feb 2024, 4:00 am
No. 1151 at paras. 17, 20 (C.A.), Eli Lilly & Co. v. [read post]
26 Jun 2013, 6:43 am
On the same day, no less, the IPKat learns of the consultation on the 15th draft of the Rules of Procedure of the UPC, and of Mr Justice Arnold’s exciting decision in Eli Lilly & Company v Janssen Alzheimer Immunotherapy (let’s call them Lilly and JAI). [read post]
23 Feb 2016, 1:53 am
Mrs Justice Rose is go go go in Lilly v Janssen stay applicationStays of proceedings are not easy in UK courts, as Janssen found out last week in Eli Lilly v Janssen Sciences [2016] EWHC 313, where Mrs Justice Rose refused to stay Lilly's revocation and declaration of non-infringement (DNI) action brought against Janssen's divisional patent - EP (UK) 2 305 282. [read post]
15 Jan 2010, 8:00 am
Eli Lilly & Co., Inc., 2007 WL 2261693 (D.S.C. [read post]
22 Mar 2016, 6:12 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
2 Jul 2014, 1:42 pm
Eli Lilly & Co., 119 F.3d 1559 (Fed. [read post]
8 Jan 2009, 4:07 am
Eli Lilly & Co., 536 F. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Doryx (Doxycycline) – US: Warner Chilcott files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Ebixa (Memantine) – Canada: Duty of good faith patent prosecution: Lundbeck v Ratiopharm (IP Osgoode) Focalin (Dexmethylphenidate) - US: Settlement announced in Focalin infringement dispute involving Celgene, Novartis Pharmaceuticals and Teva Pharmaceuticals (Patent Docs) Gemzar (Gemcitabine) – US: Patent infringement… [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
7 Aug 2019, 1:42 am
The IPCom guidance are provided for readers' convenience at the end of this post.The IPCom factors have since been applied in Actavis v Pharmacia [2014] EWHC 2265 (stay was ordered), and Eli Lilly v Janssen Sciences [2016] EWHC 313 (stay was not ordered) (IPKat post here).David Stone (sitting as a Deputy High Court Judge), applied the IPCom guidance to the fact of the case in Coloplast v Salts. [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map… [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
20 Dec 2023, 5:00 am
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
20 Mar 2009, 2:05 am
Eli Lilly & Co., 774 F.2d 830, 835 (7th Cir. 1985); Martinkovic v. [read post]
3 Mar 2016, 5:19 am
See Larkin v. [read post]
